Showing results (331-340 of 428) with videos related to
Sort By:
Pageof 43
Cerebrovascular Diseases (Basel, Switzerland)|February 14, 2022
Association of Elevated Body Mass Index with Functional Outcome and Mortality following Acute Ischemic Stroke: The Obesity Paradox RevisitedAlis J Dicpinigaitis, Kieran E Palumbo, Chirag D Gandhi, et al.Stroke|March 13, 2026
Impact of Laterality on Inpatient Outcomes and Complications of Middle Cerebral Artery Acute Ischemic StrokeStaton Albert, Aarti Kishore Jain, Aryan Malhotra, et al.Acta Neurochirurgica|March 18, 2026
Cerebral vasospasm following arteriovenous malformation rupture: a population-based longitudinal studyIsaac B Thorman, Eris Spirollari, Tamer Mubarak, et al.Neurocritical Care|December 3, 2010
Intracerebral monitoring of silent infarcts after subarachnoid hemorrhageRaimund Helbok, Ravi Chandra Madineni, Michael J Schmidt, et al.Acta Neurochirurgica|August 27, 2025
Impact of acute alcohol intoxication and alcohol dependence on outcomes after subarachnoid hemorrhageIsaac B Thorman, Ankita Jain, Elad Mashiach, et al.Neurology|February 7, 2023
Patient Relevance of the Modified Rankin Scale in Subarachnoid Hemorrhage Research: An International Cross-sectional SurveyNaomi Niznick, Victoria Saigle, Maria Luisa Marti, et al.Journal of Neurosurgery|July 3, 2008
Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhageGrace H Kim, Christopher P Kellner, David K Hahn, et al.Annals of Neurology|April 29, 2014
Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcomeJan Claassen, David Albers, J Michael Schmidt, et al.Neurosurgical Focus|July 28, 2022
Cerebral vasospasm following arteriovenous malformation rupture: a population-based cross-sectional studyAlis J Dicpinigaitis, Eric Feldstein, Steven D Shapiro, et al.International Journal of Stroke : Official Journal of the International Stroke Society|August 24, 2021
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trialAndrew M Naidech, James Grotta, Jordan Elm, et al.Pageof 43